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Abstract
Background Chronic cough is a major health problem worldwide and patients are best managed in specialised tertiary centres. 
Little information is available on the characteristics of chronic cough patients in several European countries, including Italy.
Aims We report on the demographic, anthropometric and clinical features of a large Italian population of adult chronic cough 
outpatients (about 1200), who were referred to a specialised clinic in Florence, Italy, from 2008 to 2018.
Methods Demographic, environmental, lifestyle and clinical information was collected at enrolment by means of a custom-
designed electronic questionnaire that only allowed for uniform responses. A subjective measure of cough-related discom-
fort (cough score) was also obtained using a modified Borg Scale. A multivariable logistic regression model was defined to 
identify the patients’ characteristics associated with the cough score.
Results The characteristics of the examined population (n = 1204 outpatients) were strikingly similar to those described 
elsewhere. Female patients outnumbered the males [n = 847 females, (70.0%)]; both females and males displayed the same 
average cough score. The median age of outpatients was 61 (quartile 1 = 48; quartile 3 = 70) years; age and cough duration 
were unrelated to the cough score. Nasal obstruction, coughing during consultation, coughing during meals, throat clearing 
and the presence of respiratory abnormalities were correlated with the degree of discomfort caused by coughing.
Discussion The features of chronic cough patients are similar worldwide. The process of cough reflex hypersensitisation 
may soothe sex-related perceptual differences, leading to similar levels of discomfort.
Conclusions There seem to be clinical indicators that help in assessing the level of cough-related discomfort.
Keywords Chronic cough · Cough score · Cough-related discomfort
Introduction
It is well known that cough represents one of the commonest 
complaints worldwide. A substantial degree of morbidity is 
associated with chronic cough, generally defined as a cough 
being the only or prevalent symptom lasting for at least 
8 weeks in the absence of obvious radiographic evidence of 
lung disease [1–3]. Although chronic cough may character-
ise several respiratory and extra-respiratory disorders such 
as asthma, pulmonary fibrosis, chronic obstructive pulmo-
nary disease and gastro-oesophageal reflux, many chronic 
cough patients have virtually no accompanying symptoms, 
so that the underlying causes remain difficult to detect. Sev-
eral international guidelines [1, 2], published by different 
scientific assemblies, are currently available for the assess-
ment of chronic cough patients, and it seems desirable for 
patients with chronic cough to be referred to a specialist 
clinic for optimal evaluation [3]. Nonetheless, the num-
ber of specialised centres is limited in Italy and indeed the 
Cough Clinic at the Careggi University Hospital in Florence 
appears to be the only institutional unit specifically devoted 
to the management of adult chronic cough patients.
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This manuscript reports on the demographic and clini-
cal features of an unselected sample of Italian adult outpa-
tients with chronic cough who were referred to the Careggi 
Cough Clinic; in addition, it aims to determine the asso-
ciation between the patients’ clinical characteristics and a 
subjective measure of the discomfort caused by their cough.
Methods
We enrolled all adult outpatients with chronic cough (i.e. 
lasting longer than 2 months) [1–3] who were consecutively 
referred to our Cough Clinic between 2008 and 2018. The 
exclusion criteria were patients with a history of recent 
(< 4 weeks) respiratory infection and/or evidence of active 
lesions documented by a recent (within 2 months) chest 
X-ray. All procedures complied with the Helsinki Declara-
tion and the study was approved by the local Institutional 
Review Board (OSS_14131). The study followed the guide-
lines for observational studies [4].
Data collection
By using a custom-designed electronic questionnaire, we 
collected a set of demographic, environmental, lifestyle 
and clinical information for each patient at enrolment. The 
questionnaire comprised several distinct items and was con-
ceived to only allow for unified responses, thus making its 
administration completely independent of the operator. A 
subjective measure of cough-related discomfort (hereafter 
termed “cough score”) was also obtained by using a 0–9 
modified Borg Scale (see supplement). The time required 
for the questionnaire administration, cough score and clini-
cal assessment at consultation was 40–50 min. Additional 
details of the questionnaire and cough score assessment are 
available as supplementary material.
Statistical analysis
Categorical variables were presented as numbers with the 
corresponding percentages, whereas continuous variables 
were summarised through either the mean and standard devi-
ation (SD) if normally distributed (Shapiro–Wilk test), or the 
median and Q1–Q3 quartiles. Based on its distribution, the 
cough score was dichotomised into < 3 vs. ≥ 3 (“the cough 
does not bother me at all or causes only slight discomfort” 
vs. “the cough bothers me or causes me moderate, severe, 
very severe, or extremely severe discomfort”, see Supple-
ment for additional details). The relationships between the 
dichotomised cough score and the patients’ characteristics 
were assessed by using Fisher’s exact test, the Chi-squared 
test and the Wilcoxon rank-sum test where appropriate. A 
multivariable logistic regression model was defined with the 
dichotomised cough score as the outcome. A stepwise selec-
tion procedure of covariates was used, with p ≤ 0.20 to enter 
the model and p ≤ 0.10 to stay in the model [5]. Linearity 
assumption for quantitative variables and interactions among 
independent variables were also evaluated in the model.
All the statistical tests were two-tailed and p values < 0.05 
were considered significant. All the analyses were performed 
using the SAS 9.4 statistical software (SAS Institute, Cary, 
NC, USA).
Results
The general and dichotomised demographic, anthropometric 
and clinical characteristics of the patient cohort (n = 1204, 
70.4% females) are reported in Table 1.
In the general population, the median age was 61 (48–70) 
years, with no significant difference between males or 
females (Fig. 1; p = 0.8154). The overall mean body mass 
index (BMI) was 25.8 ± 4.4 kg/m2, with more than half of 
the sample overweight or obese (BMI ≥ 25 kg/m2). Less than 
10% of patients were smokers, with average daily smoking 
of ten cigarettes (5–20). Only 21 patients (9 women) with 
previously undiagnosed COPD were included in the study. 
The median duration of cough was 3 years (1–10) and dis-
tribution was right-skewed, with more than 40% of patients 
referring for a cough lasting 5 years or longer. As shown in 
Fig. 2, the overall median cough score was 5 (3–7) with no 
significant difference between males or females (p = 0.4733). 
The majority of patients (about 59%) were not on any treat-
ment for their cough at the time of consultation. Treatment 
taken by the remaining patients at the time of consulta-
tion—or during the period immediately preceding—mostly 
included anti-reflux drugs, asthma medications, antibiotics 
and over-the-counter antitussives.
Patients with a cough score ≥ 3 had more frequent accom-
panying symptoms and clinical signs than those with a < 3 
cough score (Table 1; p < 0.05 for exertional wheezing, night 
cough, cough under effort, post-nasal drip (PND) sensation, 
voice changes, frequent heartburn, regurgitation, globus sen-
sation, cough on walking, bending, talking/phoning, eating, 
after meals, evoking epigastric pain; cough worsened by 
changes in body position, strong smells and upper airway 
infections). Notably, among patients with < 3 cough score, 
with respect to those with a score ≥ 3, cough ensuing dur-
ing consultation (62.9% vs. 23%, respectively; p < 0.0001), 
evoking epigastric pain (26.1% vs. 13.9%; p = 0.0069) as 
well as the induction of deflation cough (40.8% vs. 24.7%, 
respectively; p = 0.0025) was more frequently observed [6, 
7]. The use of ACE inhibitors was reported by 82 outpa-
tients; the percentage of patients using ACE inhibitors with 
a cough score ≥ 3 was not significantly different from that 
among patients with a < 3 cough score (p = 0.6404).
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Table 1  Overall and 
dichotomised by cough score 
characteristics of patients at 
enrolment
ACE angiotensin converting enzyme, CS cough score, PND post nasal drip
Overall (n = 1204) CS < 3 (n = 104) CS ≥ 3 (n = 1054) p value
Sex, females, n (%) 847 (70.4) 70 (67.3) 759 (70.7) 0.4733
Age, years, median (Q1, Q3) 61 (48, 70) 65 (46.5, 72.5) 61 (48, 69) 0.1369
BMI, kg/m2, median (Q1, Q3) 25.8 ± 4.4 25.8 ± 4.2 25.8 ± 4.4 0.8046
Smoking status, n (%) 0.3035
 Never 735 (61.9) 69 (66.4) 661 (61.7)
 Ex 349 (29.4) 24 (23.1) 321 (29.9)
 Current 104 (8.8) 11 (10.6) 90 (8.4)
ACE inhibitor use, n (%) 82 (6.9) 6 (5.8) 75 (7.0) 0.6404
Seasonal cough, n (%) 0.002
 Continuous 728 (80.3) 52 (67.5) 672 (81.4)
 Periodic 88 (9.7) 16 (20.8) 72 (8.7)
 Seasonal 91 (10.0) 9 (11.7) 82 (9.9)
Asthma familiarity, n (%) 252 (21.9) 17 (16.7) 233 (22.4) 0.1812
Allergy symptoms, n (%) 357 (35.2) 31 (32.0) 324 (35.6) 0.475
Exertional wheezing, n (%) 408 (34.5) 25 (24.0) 378 (35.3) 0.0206
Exceptional dyspnoea, n (%) 438 (37.4) 30 (28.9) 404 (38.1) 0.0622
Sputum, n (%) 314 (26.6) 26 (25.2) 283 (26.5) 0.7907
Night cough, n (%) 625 (52.7) 45 (43.3) 576 (53.6) 0.0413
Cough under effort, n (%) 441 (38.2) 25 (24.3) 412 (39.4) 0.0025
Cough in cold air, n (%) 431 (37.3) 30 (29.4) 400 (38.2) 0.0798
PND sensation, n (%) 352 (30.1) 19 (18.3) 329 (31.1) 0.0063
Throat clearing, n (%) 897 (76.3) 69 (66.4) 823 (77.4) 0.0111
Voice changes, n (%) 620 (52.5) 44 (42.3) 570 (53.3) 0.0326
Frequent heartburn, n (%) 254 (21.4) 14 (13.5) 237 (22.1) 0.0395
Indigestion, n (%) 399 (33.9) 29 (28.2) 366 (34.4) 0.2033
Frequent regurgitation, n (%) 236 (19.9) 12 (11.5) 222 (20.8) 0.0248
Belching/burping, n (%) 466 (39.3) 36 (34.6) 426 (39.7) 0.3105
Globus sensation, n (%) 536 (45.9) 26 (25.5) 509 (48.1) < 0.0001
Cough on walking, n (%) 653 (56.1) 37 (35.6) 611 (57.9) < 0.0001
Cough on bending, n (%) 310 (26.7) 16 (15.7) 290 (27.5) 0.0096
Cough on talking/phone, n (%) 799 (67.7) 43 (41.8) 753 (70.3) < 0.0001
Cough on eating, n (%) 314 (26.7) 16 (15.4) 295 (27.7) 0.0066
Cough after meals, n (%) 400 (34.0) 24 (23.1) 375 (35.2) 0.0132
Deflation cough, n (%) 385 (39.2) 23 (24.7) 360 (40.8) 0.0025
Cough during visit, n (%) 622 (59.0) 23 (23.0) 596 (62.9) < 0.0001
Respiratory signs, n (%) 370 (32.1) 26 (25.5) 339 (32.5) 0.1453
Evoked epigastric pain, n (%) 285 (25.1) 14 (13.9) 267 (26.1) 0.0069
Cough worsened by, n (%)
 Certain foods/beverages 
(including alcohol, coffee, 
cold drinks)
199 (19.6) 13 (16.1) 186 (20.1) 0.384
 Climate changes 250 (24.7) 15 (13.6) 234 (25.2) 0.1784
 Changes in body position 313 (30.9) 12 (14.8) 301 (32.5) 0.001
 Environmental exposure (dust, 
tobacco smoke, smog)
195 (19.2) 10 (12.4) 183 (19.7) 0.1047
 Laughing 157 (15.5) 13 (16.1) 143 (15.4) 0.8818
 Stress 95 (9.4) 8 (9.9) 85 (9.2) 0.833
 Strong smells 320 (31.6) 16 (19.8) 304 (32.8) 0.015
 Upper airway infections 122 (12.0) 19 (23.5) 103 (11.1) 0.0011
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Fig. 1  Frequency distribution of age (years) by gender at enrolment
Fig. 2  Frequency distribution of cough score by gender at enrolment
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The results of the multivariable logistic regression analy-
sis (Table 2) showed that the patients’ characteristics most 
frequently associated with a cough score ≥ 3 were stuffy 
nose (odds ratio (OR) 2.45, 95% confidence interval (CI) 
1.13–5.35; p = 0.0241), throat clearing (OR 2.2, 95% CI 
1.11–4.38; p = 0.0239), coughing on eating (OR 3.11, 95% 
CI 1.32–7.33; p = 0.0095), coughing during the visit (OR 
5.88, 95% CI 2.86–12.1; p < 0.0001) and the presence of 
respiratory signs (e.g. wheezing and/or crackles) on clini-
cal examination (OR 2.29, 95% CI 1.12–4.72; p = 0.0241). 
Conversely, antacid and antihistamine drug use was associ-
ated with a lower cough score (Table 2; OR 0.39, 95% CI 
0.19–0.80, p = 0.0104; and OR = 0.28, 95% CI 0.11–0.72, 
p = 0.0080, respectively). Age, sex and cough duration were 
all unrelated to the cough score at enrolment (p > 0.05).
Discussion
This is the first report on the demographic, anthropometric 
and clinical characteristics of an unselected group of adult 
chronic cough outpatients referring to a tertiary care centre 
in Italy. It confirms that age and sex distribution in this large 
group of patients overlaps that reported in previous popula-
tion studies performed in other countries, despite obvious 
cultural, environmental and behavioural differences [8]. 
Accordingly, we documented a preponderance of females 
suffering from a primary complaint of chronic cough in 
our study [9, 10]. This finding is in keeping with the notion 
of females having a heightened cough reflex sensitivity as 
revealed by inhalational challenges [11–14] and in response 
to treatment with ACE inhibitors [15]. However, the fact 
that the distribution of cough scores was virtually identical 
in males and females indicates that gender is unrelated to the 
magnitude of the perceived discomfort caused by the cough. 
This finding seems to be in contrast with the observations 
derived from a recent functional magnetic-resonance study 
showing a much greater activation in the somatosensory 
cortex of healthy females than in males during an inhala-
tional capsaicin challenge [8]. Since chronic cough can be 
regarded as a clinical syndrome characterised by neuronal 
hypersensitivity [16], it may be that the processes underlying 
hypersensitisation of the cough reflex could have blunted the 
natural sex-related perceptual differences, leading to com-
parable degrees of perceived discomfort between male and 
female chronic coughers.
We found that the mean cough duration in our population 
was about 3 years, although many patients reported a cough 
lasting longer than 25 years (data not shown). Nonetheless, 
cough duration was unrelated to the magnitude of the per-
ceived discomfort. A likely explanation for this finding may 
be habituation to the burden imposed by the cough. Over 
time, patients reportedly develop different strategies to cope 
with their disability and, conceivably, the better their strat-
egy the less is the discomfort.
This study has some limitations. First, these patients 
are not representative of all patients with chronic cough. 
Indeed, a patient usually receives medical attention from 
a general practitioner, then from a specialist and, eventu-
ally, from a tertiary care centre. Consequently, most patients 
with chronic cough due to common causes, such as chronic 
obstructive pulmonary disease, heart failure or use of ACE 
inhibitors, are treated in other settings. The patients being 
treated at the Careggi Cough Clinic are therefore those with 
undiagnosed causes or who have been unsuccessfully treated 
for selected causes.
Second, the results do not give a reliable picture of the 
epidemiology of chronic cough in Italy. Indeed, the vast 
majority of the patients (about 80%) were referred from 
areas close to the Florentine clinic, whereas only a minor-
ity were from regions outside Tuscany. Nonetheless, the 
fact that the demographic and clinical characteristics of the 
patients included in this survey were comparable to those 
of studies performed in other world areas [8] points to the 
possibility that chronic cough phenotypes are similar all over 
the world. If this is the case, the possibility that chronic 
cough patients from other Italian areas have comparable 
characteristics also seems likely.
Another limitation may be the lack of a more objective 
evaluation of the burden of cough in our patients. Com-
mon methods for the quantitative analysis of cough severity 
include objective recordings of cough frequency and admin-
istration of cough-related quality-of-life questionnaires, such 
as the Leicester Cough Questionnaire (LCQ) [17]. In real life 
settings, objective cough frequency recording techniques are 
difficult for several reasons, mainly the poor availability of 
validated and time-efficient devices on the market. On the 
Table 2  Multivariable logistic regression model with outcome of 
dichotomised cough score (CS) at enrolment (CS < 3 vs. CS ≥ 3)
PPI proton pump inhibitors
OR 95% CI p value
Sex (females vs. males) 1.11 0.56–2.20 0.7607
Age (≥ 65 vs. < 65 years) 0.62 0.32–1.18 0.1423
Cough duration (years) 1.03 0.98–1.09 0.1861
Nasal obstruction 2.45 1.13–5.35 0.0241
Throat clearing 2.2 1.11–4.38 0.0239
Cough on waking up 1.79 0.95–3.39 0.0731
Cough during eating 3.11 1.32–7.33 0.0095
Cough during visit 5.88 2.86–12.1 < 0.0001
Respiratory signs 2.29 1.12–4.72 0.0241
Drugs at admission: antacid 0.39 0.19–0.8 0.0104
Drugs at admission: antihistamine 0.28 0.11–0.72 0.0080
Drugs at admission: PPI 0.60 0.31–1.18 0.1389
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other hand, administration of the LCQ would be difficult 
since the tool has not been validated in Italy and it would 
extend the duration of each consultation somewhat beyond 
the acceptable time limits. Interestingly, we found a strong 
association (OR = 5.88) between “coughing during the visit” 
and the cough score. In short, patients who coughed during 
the consultation had a sixfold higher possibility of a cough 
score > 3. We suggest that coughing during visit could be 
taken as an additional indicator of the magnitude of the dis-
turbance caused by coughing in chronic cough patients.
In conclusion, this is the first report on the characteristics 
of a large population of chronic cough outpatients who were 
referred to a specialised cough clinic in Italy. Notably, these 
characteristics appear to mirror those described in other pop-
ulation studies performed worldwide [8]. Our findings are 
therefore in keeping with the possibility that chronic cough 
patients have a single common clinical entity. Finally, based 
on a purely clinical approach, we have identified useful clini-
cal indicators that may help to assess cough severity. Further 
studies are needed to ascertain whether these clinical indi-
cators could also be useful in longitudinal studies aimed at 
determining the prevailing causes of chronic cough and the 
outcomes of therapeutic interventions.
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